葛根素对阿司匹林抵抗患者血小板功能影响的临床研究(3)
第1页 |
参见附件。
[5] Dillinger JG,Drissa A,Sideris G,et al. Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease [J]. Am Heart J,2012,164:600-606.
[6] 陈秋晨,于兆进,孙海刚,等.复方曲肽注射液对血小板聚集和血栓形成影响的实验研究[J].中国实验血液学杂志,2011,19(1):193-196.
[7] 姚丹,丁选胜.葛根素药理作用机制探讨及临床应用[J].中国临床药理学与治疗学,2008,13(4):468-474.
[8] 黎金庆,周合冰,郭金成,等.血栓弹力图评价血小板ADP受体抑制率对血凝块形成的影响[J].血栓与止血学,2011,7(3):121-123.
[9] Montalescot G,Sideris G,Meuleman C,et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (assessment of the best loading dose of clopidogrel to blunt platelet activation,inflammation and ongoing necrosis) trial [J]. J Am Coll Cardiol,2006,48: 931-938.
[10] Kastrati A. New anti-platelet agents:the end of resistance [J]. Thromb Res,2012,130(Suppl 1):53-55.
[11] Vidali M,Rolla R,Parrella M,et al. Role of the laboratory in monitoring patients receiving dual antiplatelet therapy [J]. Int J Lab Hematol,2012,34:484-494.
[12] 邓东红,黄艳平,杨杰,等.芒果苷对血小板聚集和释放CD62P的影响[J].中药材,2011,34(9):1408-1413.
(收稿日期:2012-10-23 本文编辑:冯 婕)
您现在查看是摘要介绍页,详见PDF附件(2883kb)。